Clinical Trials Logo

Blood Pressure clinical trials

View clinical trials related to Blood Pressure.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06405880 Not yet recruiting - Diabetes Clinical Trials

Pharmacist Case Finding and Intervention for Vascular Prevention Trial

PRxOACT
Start date: September 2024
Phase: N/A
Study type: Interventional

Heart disease is a common and serious medical condition which causes nearly one in every three deaths worldwide every year. The factors which increase people's risk for heart disease are well-known, but there needs to be more support given to people to reduce their risk of heart disease. Pharmacists are front line primary healthcare providers who see patients more frequently than any other healthcare provider and can help people reduce their risk of heart disease. This research project aims to see whether a pharmacist-led intervention can help people reduce their risk of heart disease. The potential impact of this project is to empower people to understand how to reduce their risk of heart disease and reduce the burden of heart disease on the community.

NCT ID: NCT06383000 Not yet recruiting - Blood Pressure Clinical Trials

Assessment of Effectiveness of Continuous Non-invasive Haemodynamic Monitor by Compared to Invasive Blood Pressure and Pulse Oximeter Monitoring on Patients Undergoing General Anesthesia Surgeries for More Than 60 Minutes

Start date: June 1, 2024
Phase:
Study type: Observational

The goal of this observational study is to assess whether the continuous non-invasive haemodynamic monitor MOH200 (measuring blood pressure as well as pulse rate) is effective or not in people undergoing general anesthetic surgeries for more than 60 minutes with planned invasive blood pressure and pulse oximeter monitoring. Researchers will compare blood pressure data derived from MOH200 to the invasive blood pressure (IBP) data to see if the MOH200 is effective to measure the blood pressure of a surgical person. Also, researchers will compare pulse rate data drived from MOH200 to that from the pulse oximeter to see if the MOH200 is effective to measure the pulse rate of a surgical person. Participants will be asked to be applied with MOH200 monitoring while IBP monitoring and pulse oximeter are applied. And after 30 minutes of the surgery, researchers will monitor the adverse effects occurred on the skin of participants to assess the safety of MOH200.

NCT ID: NCT06317168 Not yet recruiting - Blood Pressure Clinical Trials

SIMPLifying Elements of Standardized Automated Office Blood Pressure Measurements (Pilot Study)

SIMPLE-AOBP
Start date: May 1, 2024
Phase: N/A
Study type: Interventional

This study aims to assess whether removing single elements of the standardized office BP measurement procedure will affect the accuracy towards the mean awake ambulatory BP. Four arms are planned in a randomized order: 1) full standardized procedure, 2) standardized procedure but with cuff placed on a sleeve, 3) standardized procedure but arm resting vertically, 4) standardized procedure but with non-validated device. This is a pilot study to inform on the sample size required to perform adequately powered large scale studies.

NCT ID: NCT06283758 Not yet recruiting - Hypertension Clinical Trials

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE HTN-III)

Start date: March 2024
Phase: N/A
Study type: Interventional

This seamless two-stage phase II/III clinical trial aims to evaluate the efficacy and safety of a novel focused power ultrasound mediated inferior perirenal adipose tissue modification therapy for essential hypertension. Stage 1 is a phase II, multicenter, open-label, randomized trial to determine the optimal treatment strategy. Stage 2 is a phase III, multicenter, randomized, double-blind trial investigating the efficacy and safety of optimal treatment strategy compared to sham control.

NCT ID: NCT06272318 Not yet recruiting - Hypertension Clinical Trials

Vital Signs Blood Pressure Trial

Start date: June 1, 2024
Phase:
Study type: Observational

The purpose of this study is collect subject vitals with a blood pressure cuff, electrocardiogram (ECG), and photoplethysmogram (PPG). This data can then be used to develop a reliable, accurate, noninvasive, and continuous blood pressure monitoring device.

NCT ID: NCT06247254 Not yet recruiting - Blood Pressure Clinical Trials

Telehealth-Enhanced Assessment and Management

TEAMS-BP
Start date: October 2024
Phase: N/A
Study type: Interventional

TEAMS-BP is a Patient-Centered Outcomes Research Institute (PCORI)-funded trial under the Phased Large Awards for Comparative Effectiveness Research (PLACER) funding mechanism to evaluate two comprehensive and evidence-based strategies for managing blood pressure (BP) following stroke.

NCT ID: NCT06229873 Not yet recruiting - Blood Pressure Clinical Trials

Smartphone App-guided Inspiratory Muscle Strength Training for Lowering Systolic Blood Pressure

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

This clinical trial aims to assess the efficacy of inspiratory muscle strength training (IMST) guided by a smartphone app vs. IMST delivered in a clinical research setting for lowering systolic blood pressure in adults 18 years and older with elevated blood pressure. Participants will perform IMST for 5 minutes a day, 6 days a week, for 6 weeks.

NCT ID: NCT06198855 Not yet recruiting - Hypertension Clinical Trials

Automated Measurement of Blood Pressure in Waiting Room (AMBP-waiting)

AMBP-waiting
Start date: March 1, 2024
Phase:
Study type: Observational

The investigators will study 500 patients with any indication for 24-hours Ambulatory Blood Pressure Monitoring (ABPM). In this study will compare Blood Pressure measurements with an original automatic device every 5 minutes during 20 minutes while the subject waits room for appointment, against ABPM results.

NCT ID: NCT06104501 Not yet recruiting - Blood Pressure Clinical Trials

Validation of the Blood Pressure Monitoring Function

Start date: October 20, 2023
Phase:
Study type: Observational

High blood pressure is a major risk factor for cardiovascular diseases, stroke, and kidney disorders. Accurate blood pressure monitoring is crucial for the diagnosis, treatment, and prevention of complications related to high blood pressure. In recent years, due to the rapid development of wearable devices and mobile technology, wearable blood pressure monitors have gradually become a non-invasive and convenient method for blood pressure monitoring. However, the accuracy of these devices has not been fully established. This study aims to validate the performance of RadiHeart (an application program) in blood pressure measurement.

NCT ID: NCT06097884 Not yet recruiting - Blood Pressure Clinical Trials

Healthy School mEAls With Less Salt:an Action to Reduce Salt Intake in School Meals for Children in Rural China

HEALS-child
Start date: October 2023
Phase: N/A
Study type: Interventional

This study aims to assess the impact of the HEALS-Child action project on children's health in rural China. The goal of the project is to evaluate the effectiveness, feasibility, safety and cost-effectiveness of two salt reduction strategies: replacing usual salt with salt substitute in school meals, and replacing bowls with trays in school cafeteria. The study has two parts: the main study evaluates the salt substitute intervention, and the ancillary study evaluates the tray intervention. In the main study, over 16000 students from around 320 elementary or junior high school in rural China will be cluster-randomized into the two groups: 1. Salt substitute 2.usual salt. The primary outcome in the main study will be the change in systolic blood pressure. In the ancillary study, over 500 students from 10 elementary or junior high school will be cluster-randomized into the two groups: 1. meal trays 2.bowls. The primary outcome in the ancillary study will be the change in spot urine sodium. The interventions will last over 1 years. To evaluate the impact of interventions, 50 students were randomly selected from each school.